Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pamela B Allen
Hematologic Toxicity Is Rare in Relapsed Patients Treated With Belinostat: A Systematic Review of Belinostat Toxicity and Safety in Peripheral T-Cell Lymphomas
Cancer Management and Research
Oncology
Related publications
MDS as a Cause for Prolonged Hematologic Toxicity After Treatment With Cd19 Targeted Car-T Cell Therapy in Patients With Relapsed Refractory Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preclinical Efficacy of Belinostat in Combination With Zidovudine in Adult T-Cell Leukemia-Lymphoma
Retrovirology
Virology
Infectious Diseases
Tanslocations Involving Cd28 Are Rare in Peripheral T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Single Center Phase II Study of Ixazomib in Patients With Relapsed or Refractory Cutaneous or Peripheral T-Cell Lymphomas
American Journal of Hematology
Hematology
Survival Benefit With Novel Agents in Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (Ptcl): The Columbia University Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High-Dose Therapy With Autologous Stem Cell Transplantation in Patients With Peripheral T Cell Lymphomas
Bone Marrow Transplantation
Transplantation
Hematology
Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pralatrexate in Patients With Recurrent or Refractory Peripheral T-Cell Lymphomas: A Multicenter Retrospective Analysis
Scientific Reports
Multidisciplinary
Guest Editorial: Peripheral T-Cell Lymphomas: Progress Is Not “Peripheral”, but “Central”
International Journal of Hematology
Hematology
